about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionEffects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implicationsCytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasisGenomic approaches for understanding dengue: insights from the virus, vector, and hostGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionDNA Damage: From Chronic Inflammation to Age-Related DeteriorationTargeted immune therapy of ovarian cancerEngineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapyGenome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cellsInterleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells.Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cellsIncreasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionSilencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancerThy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging.Genetics, genomics, and evolutionary biology of NKG2D ligands.Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation.Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.Immunity and immune suppression in human ovarian cancer.Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.Performance of genetic risk factors in prediction of trichloroethylene induced hypersensitivity syndrome.Revealing the molecular signatures of host-pathogen interactions.IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells.NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesThe immunogenetics of Psoriasis: A comprehensive review.NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d.The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathiesChimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.The janus head of T cell aging - autoimmunity and immunodeficiency.Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Polymorphism rs3828903 within MICB Is Associated with Susceptibility to Systemic Lupus Erythematosus in a Northern Han Chinese Population.CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditisExpression and prognostic significance of unique ULBPs in pancreatic cancerA Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression.
P2860
Q21131219-D1F71849-5D3B-41CF-A4C5-FAAFAC04E9AEQ26774934-D8298A3E-C864-4653-9F04-E9552EE34E01Q27334358-F49F315F-1605-4266-BFF1-E45B2B08E5B3Q28073351-40D52AD2-05A9-4FE8-80CC-D1918D7081F5Q28076151-08815B24-2267-4772-92E7-EAD33689DC05Q28078628-8D4226F2-E22F-4865-A1AA-6CF029B55BE8Q28082828-2581AEE9-4A1E-45D3-9C5F-C412292CA430Q28485036-9F158E06-D259-417A-89D1-16A545AB0DA7Q28943386-B10DECDD-FC79-4BCF-9711-49D1C4638313Q33445569-2DFEEFED-E534-4AB8-93E9-91EA4497F9F3Q33497623-CABF7091-A550-41B8-9F6B-4AFC54492645Q33564357-01B0E116-E06A-4149-88C8-2166D7E68BF2Q33761979-525EC24A-6A43-43DB-A1B6-A928C8A05C62Q33815894-9C8E2EEF-82A9-4DBF-97DE-78545868E400Q33987473-94B41E26-B32B-41E9-BD58-25CED8822AA0Q34058678-00716099-359C-438B-ABF3-A00D3D9DDC63Q34489980-5BC9A9E6-401A-4EB5-A638-DBC455510080Q34618454-246ACE8D-7F74-459A-9FC5-236192ADE7E5Q34806981-2042F984-C35D-4036-AE2D-897193332CDCQ34983200-78583975-DE57-41A1-ADF6-55E68277B357Q35031677-CABC8539-FF72-4933-897A-4310CF3B90D1Q35083496-E351587A-EFD5-4DC5-A005-9F71A9A66457Q35138135-F3E9DBEE-2A7D-486E-BD80-337146929FF1Q35287627-2C433AB1-9250-412B-BB0B-74B1C7E4B56BQ35661383-7C7909C5-6F67-4BAE-9D08-C59378864F68Q35865513-92644B0D-30C7-4325-B1C4-DBDB272F86E3Q35905785-BEA937D3-A070-4DA1-9C60-D5E2801157BDQ35995167-078090C1-1624-4C5F-81C0-C0D7914933A9Q36215821-775B4184-D600-48F6-89FB-EBFFBA6C991DQ36236780-EED9F69C-9DDE-4942-8C51-B551B0F15239Q36469236-FCC8C9DB-1BF9-45BB-B0AC-8322C7D13C75Q36685376-19971C57-7AC9-45FF-B429-187F4A69AB8DQ36720681-085ABA4E-4567-4783-B352-315FCFE537DEQ36757142-272930B0-FD45-4BE5-90C7-8E80EC6C63D4Q36898613-0E19CE24-6280-4C37-B52B-9367E2DE0B08Q37077413-E3B7D592-AA13-476C-9C81-E1EC549D84E1Q37084305-0C05F713-944D-447B-95E1-B69552471143Q37109625-ED02E3D2-7B16-4E55-B8C9-8EC07AC95C8CQ37229770-6F48E7AB-8ACC-47C7-BD17-ECCC5F31E57AQ37462652-1629734C-78B6-49DA-AFF6-5C909FCFE20E
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
NKG2D ligands: key targets of the immune response.
@ast
NKG2D ligands: key targets of the immune response.
@en
NKG2D ligands: key targets of the immune response.
@nl
type
label
NKG2D ligands: key targets of the immune response.
@ast
NKG2D ligands: key targets of the immune response.
@en
NKG2D ligands: key targets of the immune response.
@nl
prefLabel
NKG2D ligands: key targets of the immune response.
@ast
NKG2D ligands: key targets of the immune response.
@en
NKG2D ligands: key targets of the immune response.
@nl
P2093
P356
P1433
P1476
NKG2D ligands: key targets of the immune response
@en
P2093
Alejandro López-Soto
Antonio López-Vázquez
Beatriz Suarez-Alvarez
P304
P356
10.1016/J.IT.2008.04.007
P577
2008-07-03T00:00:00Z